On February 11, 2022 Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), reported that the Avidity management team will be participating at the following conferences (Press release, Avidity Biosciences, FEB 11, 2022, View Source [SID1234608041]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SVB Leerink 11th Annual Global Healthcare Conference
Moderated Fireside Chat
February 18th – 2:20pm ET

Cowen 42nd Annual Health Care Conference
Corporate Panel Discussion: Orphan Neuro and Neuromuscular – Sarah Boyce, CEO
March 7th, 2022 – 9:10am ET

Needham 21st Annual Healthcare Conference
Moderated Fireside Chat
April 12, 2022

Live webcasts of each event, up to date event details and an archived replay of the webcasts following each event, will be available on the "Events and Presentations" page in the "Investors" section of Avidity’s website at View Source